EMAIL THIS PAGE TO A FRIEND

R3501 Sigma

Rifampicin

≥97% (HPLC), powder

Synonym: 3-(4-Methylpiperazinyliminomethyl)rifamycin SV, Rifampin, Rifamycin AMP

Description

Frequently Asked Questions

Live Chat and Frequently Asked Questions are available for this Product.

Biochem/physiol Actions

Inhibits the assembly of DNA and protein into mature virus particles.

Mode of Action: Inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase.

Rifampicin inhibits the assembly of DNA and protein into mature virus particles. It inhibits initiation of RNA synthesis by binding to β-subunit of RNA polymerase, which results in cell death1.

Application

Rifampicin is used to treat Tuberculosis and Tuberculosis-related mycobacterial infections1. It is widely used as an antipruritic agent in the autoimmune cholestatic liver disease, primary biliary cirrhosis (PBC). It has been shown to cause hepatitis2.

Protocols & Applications

Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information

Price and Availability

Suggested Laboratory Gloves


Laboratory GlovesThis substance has been tested against several types of hand protection for CE compliance. Click below to find the recommended gloves for handling this product.



Additional Products to Explore

Cefotaxime sodium salt

plant cell culture tested, BioReagent, powder

Ethambutol dihydrochloride

antimycobacterial

Gentamicin sulfate salt

powder, BioReagent, suitable for cell culture

Isoniazid

≥99% (TLC)

Customers Also Viewed

Ethambutol dihydrochloride

antimycobacterial

Isoniazid

≥99% (TLC)

Rifampicin

plant cell culture tested, BioReagent, ≥97% (HPLC), crystalline

Rifampicin

powder, γ-irradiated

Rifampicin

VETRANAL, analytical standard

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?